Cardiovascular

Sort by Default

Display 15 Products per page

Interventional Cardiology: Implantable Pacemaker Products

$4,750.00

In 2020, the global market for implantable pacemaker products totaled nearly $3.9bn, with dual-chamber products accounting for nearly 75% of sales. Over the forecast period covered by this report, single-chamber pacemaker devices are expected to experience greater growth than the dual-chamber market, advancing at a CAGR of approximately 6.8%. Drivers include a growing prevalence of cardiovascular disease due to the aging population, the development of leadless pacemaker systems, and expanded indications. Additionally, there is strong evidence of a correlation between COVID-19 and the development of atrial arrythmias.
November 11, 2021
Find out more
Interventional Cardiology: Carotid Artery Stents and Embolic Protection Systems

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for carotid artery stents and embolic protection systems. Geographically
September 9, 2021
Find out more
Cardiac Ablation Catheters Market

$4,750.00

Cardiac rhythm disorders (also referred to as arrhythmias or dysrhythmias) involve malfunctions of the heart’s electrical system, and may be congenital (present at birth) or acquired (developing after birth).
May 6, 2021
Find out more
Extremity Replacement Implants

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for extremities replacement implants. Market forecasts and competitive analyses are provided for the shoulder, elbow, ankle, and small joint arthroplasty devices markets. Geographic segments covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.
December 21, 2020
Find out more
Respiratory Care: Noninvasive Ventilation and Airway Management Products

$4,750.00

Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).

December 17, 2020
Find out more
Neuromodulation: Spinal Cord Stimulation Devices Market

$4,750.00

Despite the severe impact of the COVID-19 pandemic on elective surgeries, global sales of neuromodulation systems for the treatment of chronic, intractable pain—which include innovative implantable spinal cord stimulation (SCS) devices and associated products—is expected to increase at a healthy CAGR of approximately 8.6%, from nearly $3bn in 2019 to an estimated $4.5bn in 2024.
July 30, 2020
Find out more
Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices

$4,750.00

This comprehensive medical market and technology report provides an overview and in-depth market analysis of devices used in the treatment of peripheral vascular disease (PVD), including peripheral arterial disease (PAD) of the lower extremities; and deep vein thrombosis (DVT) and pulmonary embolism (PE).
May 28, 2020
Find out more
Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

$4,750.00

An overview of primary neurological diseases/disorders treated with vagus nerve stimulation (VNS) and deep brain stimulation (DBS), as well as overview of VNS and DBS neuromodulation technologies, markets, competitors, sales and forecasts. Markets covered include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets.
May 8, 2020
Find out more
Drug Delivery: Transdermal Devices

$4,750.00

This comprehensive medical market and technology report provides a comprehensive discussion of transdermal drug delivery technology for the treatment of cardiovascular disease (CVD), neurological disorders, hormone replacement therapy (HRT), pain management, and genitourinary disorder management. Markets covered by this analysis include the US, Japan, the five major EU markets (France,Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.
April 15, 2020
Find out more
Interventional Cardiology: Implantable Cardioverter Defibrillators

$4,750.00

This comprehensive medical market and technology report provides an overview and in-depth market analysis of implantable cardioverter defibrillators (ICDs) used to treat forms of cardiac arrhythmia and heart failure (HF).
July 8, 2019
Find out more
Surgical Heart Valve Management Products

$4,750.00

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the surgical heart valve repair (annuloplasty) systems, surgical heart valve replacement products, and percutaneous balloon valvuloplasty (PBV) systems markets.
May 16, 2019
Find out more
Interventional Cardiology Vascular Stents

$599.00

The global market for vascular stents is being driven by the increasing prevalence of cardiovascular disease (CVD). CVD is the leading cause of death globally, responsible for over 17 million deaths annually.
January 25, 2018
Find out more
Angioplasty Catheters Market

$4,750.00

This comprehensive medical market and technology report provides an overview and in-depth market analysis of angioplasty catheters, specifically plain old balloon angioplasty (POBA), drug-coated balloon (DCB), cutting balloon, and scoring balloon catheters, used in the treatment of severe coronary artery disease (CAD) and peripheral artery disease (PAD).
November 28, 2017
Find out more
Diagnostic and Guided Interventional Cardiology Products Market

$4,750.00

This comprehensive medical market and technology report provides an overview and in-depth market analysis of diagnostic and guided interventional cardiology devices (specifically, transcatheter angiography, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted surgical systems) used in the diagnosis of cardiovascular diseases (CVDs) and guidance of minimally invasive therapies.
July 31, 2017
Find out more
Minimally Invasive Weight Loss (Bariatric) Devices Market

$4,750.00

The minimally invasive weight loss devices market (which includes laparoscopic adjustable gastric banding systems, intragastric balloon systems and implantable neuroregulators/gastric stimulation devices) was valued at more than $137m in 2016 and is expected to grow at a double-digit rate over the next 5 years. The overall market will be driven by highly favorable demographics, low penetration, strong demand for safe and effective nonsurgical weight loss therapies (filling an underserved market between weight loss drugs and drastic bariatric surgery) and increased adoption of novel, proprietary next-generation implantable weight loss technologies–particularly new/improved capsule-based intragastric balloon systems.
July 28, 2017
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Call Back

Name

Email *

Company name *

Phone number *